539730
FREDUN
Start SIP
Invest Now
Start SIP in FREDUN
Fredun Pharmaceuticals live price: ₹1648. It opened at ₹1,690 vs previous close ₹1,678; intraday high/low: ₹1,690/₹1,602. The 50 & 200 DMA stand at ₹1,634.38/₹1,405.89.
Fredun Pharmaceuticals Performance
- Low
- ₹1,602
- High
- ₹1,690
- 52 Week Low
- ₹635
- 52 Week High
- ₹1,999
- Open Price₹1,690
- Previous Close₹1,678
- Volume8,205
- 50 DMA₹1,634.38
- 100 DMA₹1,576.66
- 200 DMA₹1,405.89
Investment Returns
- Over 1 Month -9.35%
- Over 3 Month + 4.21%
- Over 6 Month + 35.98%
- Over 1 Year + 143.05%
Smart Investing Starts Here Start SIP with Fredun Pharmaceuticals for Steady Growth!
Fredun Pharmaceuticals Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 22.9
- PEG Ratio
- 0.3
- Market Cap Cr
- 778
- P/B Ratio
- 4.6
- Average True Range
- 105.91
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -4.86
- RSI
- 49.22
- MFI
- 32.69
Fredun Pharmaceuticals Financials
Fredun Pharmaceuticals Technicals
EMA & SMA
Current Price
₹1,648.00
-30.1
(-1.79%)
- Bearish Moving Average 4
- Bullish Moving Average 12
- 20 Day
- ₹1,639.15
- 50 Day
- ₹1,634.38
- 100 Day
- ₹1,576.66
- 200 Day
- ₹1,405.89
Resistance and Support
1641.58
- R3 1,769.17
- R2 1,729.58
- R1 1,681.17
- S1 1,593.17
- S2 1,553.58
- S3 1,505.17
Fredun Pharmaceuticals Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2026-02-09 | Quarterly Results | |
| 2025-11-08 | Quarterly Results | |
| 2025-09-25 | Preferential Issue of shares & Others | To consider 1. Issue Of Warrants. alia, to consider a proposal for fund raising up to Rs.120 crores by way of further public offer, rights issue, debt issue, preferential issue or any other method. |
| 2025-07-30 | Quarterly Results | |
| 2025-05-30 | Audited Results & Dividend |
Fredun Pharmaceuticals F&O
About Fredun Pharmaceuticals
- NSE Symbol
- FREDUN
- BSE Symbol
- 539730
- Managing Director & CFO
- Mr. Fredun Medhora
- ISIN
- INE194R01017
Similar Stocks to Fredun Pharmaceuticals
Fredun Pharmaceuticals FAQs
Fredun Pharmaceuticals share price is ₹1,648 As on 14 March, 2026 | 21:24
The Market Cap of Fredun Pharmaceuticals is ₹778.1 Cr As on 14 March, 2026 | 21:24
The P/E ratio of Fredun Pharmaceuticals is 22.9 As on 14 March, 2026 | 21:24
The PB ratio of Fredun Pharmaceuticals is 4.6 As on 14 March, 2026 | 21:24
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.